Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. - Wikidata - wikimedia - TriplyDB

Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes.

Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes.

http://www.wikidata.org/entity/Q34136980

about

Stem/Progenitor Cell Niches Involved in Hepatic and Biliary Regeneration Advances in Liver Regeneration: Revisiting Hepatic Stem/Progenitor Cells and Their Origin Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies Cholangiocarcinoma Current Status on Cholangiocarcinoma and Gallbladder Cancer Classification, diagnosis, and management of cholangiocarcinoma Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures Pathology of intrahepatic cholangiocarcinoma.Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reports Pancreatic recurrence of intrahepatic cholangiocarcinoma: Case report and review of the literature.What are the precursor and early lesions of peripheral intrahepatic cholangiocarcinoma?Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy.Intrahepatic cholangiocarcinoma with predominant ductal plate malformation pattern Hippo pathway activity influences liver cell fate.Pathogenesis, diagnosis, and management of cholangiocarcinoma Cancer stem cells in primary liver cancers: pathological concepts and imaging findings.Profiles of cancer stem cell subpopulations in cholangiocarcinomas.A functional microRNA library screen reveals miR-410 as a novel anti-apoptotic regulator of cholangiocarcinoma.Cholangiocarcinomas can originate from hepatocytes in mice.Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells Hepatitis C virus infection of cholangiocarcinoma cell lines.Expression and localization of sterile alpha motif domain containing 5 is associated with cell type and malignancy of biliary tree Surgical treatment of double primary liver cancer: An observational study for a rare type of tumor Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer.Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma.Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types.Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases.Keratin 19: a key role player in the invasion of human hepatocellular carcinomas.Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development.Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia.The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours (Review).Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis.Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis.Latest advances in the pathological understanding of cholangiocarcinomas.Distal bile duct carcinomas and pancreatic ductal adenocarcinomas: postulating a common tumor entity.miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.Apical membrane expression of distinct sulfated glycans represents a novel marker of cholangiolocellular carcinoma.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.

P2860

Q26765898-45D4D3F6-CB23-4931-8D08-012144EB0FF4 Q26769989-FCA1AEDE-B815-41F5-BFB3-AA6B875D89C6 Q26852049-67C3518F-3D40-4CFD-8153-C9DF4070BA37 Q27001694-D19A3405-70F7-4FBD-A714-337EE71C0480 Q28077797-B88AA29B-4738-45A0-AEAB-A312DC548CAC Q28275153-555F378A-7B92-45AC-8C4F-C9B02B053C33 Q28550991-0A530A07-C945-4232-BBBC-79EDB80B72E5 Q30235427-CD52B2BA-66FC-4473-B883-E7E36F84E8F1 Q31145862-4CDBCAE1-39BF-4AC8-A63C-F66BBEDE543B Q33580993-76001F50-1D50-49D5-A5DC-7518D7F39419 Q33594336-75879C49-8938-42FC-A285-A0A9705D43EE Q33624317-25707B56-A12F-4173-82AB-2B90C12FE1D6 Q33905633-CD42D4CB-D859-4D03-82B9-DF62B2EFC194 Q34060093-5129CDEC-23AF-460C-BA48-8C655FD4B7B4 Q34656747-26DAC532-A807-48C7-9926-2B85CCEC1E2A Q34975197-939118F7-0CFA-43C9-A135-31268B6686A8 Q35669078-A2BF1EEB-AC70-4E66-8C50-77F2D906C149 Q36040441-EFD5A050-7849-491E-80DD-0B46DABA454B Q36129118-B379E4BF-10CF-4C2E-9468-13601B63C7E2 Q36145871-980589A7-588B-401B-B3E0-B84BF5C37750 Q36255097-8804D75A-207C-4F7A-905F-6236DC0D6429 Q36339885-A2B39DC6-BF86-4786-ABB7-A9E437BE4D5A Q37175948-1A18E49D-80E7-4BFB-A8BD-6D4C82CE4B5C Q37322987-0E274C94-C37D-4F04-8DD7-F6026BF44216 Q37382474-786940DE-524F-4CCA-9649-9D43316245CE Q37552414-705107B4-CA93-4062-8C76-B19BFC61F536 Q37584658-F7FC33CB-CD0F-4128-8AD0-9D35458C2B76 Q37658691-FA0D606E-A411-459E-8FB4-EB03D9827D71 Q38040355-DA537438-302A-4AF2-A4D2-E97D8A2CE1C8 Q38101517-29A33749-E611-4E5D-B682-D0D183AC3DFD Q38185910-6509FBD4-A186-440D-9139-B4E569B573EA Q38208583-79348CEE-C7FF-42FC-BBA8-5418C3926324 Q38245527-32C9A912-A64B-4470-8E0A-8B1130C091CB Q38254084-8303B684-CD06-4F97-9E7E-56A08CDA85AE Q38613933-8385877D-FF61-485F-AA8A-D56B0E27CB3B Q38662233-BE3B3C46-5186-41B1-B150-FEEB2CB80943 Q38721397-B9CBBF00-4E3A-40DA-94E7-BF4D0E77B8D7 Q38740816-1B2BAFFC-5F1C-43A1-8DB6-3B8F206F5EB1 Q38812588-59427D0A-FB87-4353-9EC9-088BB6906EDD Q38841880-FE9AD54F-469E-4B18-A229-8DA5DF053E72

P2860

Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes.

http://www.wikidata.org/entity/Q34136980

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Histological diversity in chol ...... rent cholangiocyte phenotypes.

@ast

Histological diversity in chol ...... rent cholangiocyte phenotypes.

@en

Histological diversity in chol ...... rent cholangiocyte phenotypes.

@nl

type

label

Histological diversity in chol ...... rent cholangiocyte phenotypes.

@ast

Histological diversity in chol ...... rent cholangiocyte phenotypes.

@en

Histological diversity in chol ...... rent cholangiocyte phenotypes.

@nl

prefLabel

Histological diversity in chol ...... rent cholangiocyte phenotypes.

@ast

Histological diversity in chol ...... rent cholangiocyte phenotypes.

@en

Histological diversity in chol ...... rent cholangiocyte phenotypes.

@nl

P1433

Q34136980-ABBE0A73-F291-47AA-91A8-5D0D6CB92B48

P1476

Q34136980-ECA2E79E-957F-423B-8FB8-0C6A42B6E4CC

P2093

Q34136980-05687B94-5FDF-4667-BD0C-FC49C8CDAABF

Q34136980-13D81CB3-1230-43D0-9794-79FE662CE352

Q34136980-21A9A729-539C-402A-89D3-7F64239B6B1A

Q34136980-2A19681B-3FF7-40C0-ACC7-EFCF38EE5AA0

Q34136980-91E02D05-B25E-4B72-ACFD-279122FCA26B

Q34136980-AFCE7AC9-74A2-42ED-A083-631D97B4CE6C

Q34136980-B7D24769-F9AC-4819-98BF-95418380E191

Q34136980-C49BC6E3-3BF2-420D-BC36-5801F73D3295

Q34136980-F12EC86C-7F60-4800-A78A-9490160BBF89

P2860

Q34136980-075D9F0E-4E4A-48E3-AF99-DA1C254446E8

Q34136980-1191348D-EFC7-4975-B097-056E18B7661A

Q34136980-14789ADA-E928-4C44-A17E-AE8FB05B01C3

Q34136980-1C4B60AE-1E0D-4239-9B0F-420722C290F0

Q34136980-208079F4-9371-46FA-B895-2D12F6247284

Q34136980-2FC707CB-7A45-4ABA-A1E2-F09A402759C4

Q34136980-386AE956-3CC6-4EE5-BB30-6D2F76980166

Q34136980-418C2824-1F82-4AF5-95CF-54CDC0CACF06

Q34136980-46552468-78F1-4680-ABD5-FC9E4B20D3BF

Q34136980-59603BBA-6250-4DF1-8953-D41DBC71B98C

P304

Q34136980-7512F88F-BAFE-4801-B842-9C530F0EE25B

P31

Q34136980-50A75A11-BCF2-40FA-9279-BAC7D279C1AF

P356

Q34136980-38370011-8592-4B9C-92BD-1F3541ADE1BC

P407

Q34136980-05DD9162-7928-4B7C-A74C-B172FB11B007

P433

Q34136980-1A9E1B84-5C25-473C-B811-DCFB629BE515

P478

Q34136980-C960A0D2-811B-4127-8981-F63D52345960

P50

Q34136980-3FD0D94C-509F-4A85-A338-907534AFFB4E

Q34136980-43662889-30AB-4FCD-9E99-4B4BBB03F4D8

Q34136980-E9D36F12-264B-4F27-ACAE-D3011250F474

Q34136980-F48F96B8-83AD-437A-B4F5-4BC77AC42941

P577

Q34136980-59EDCF75-7015-4198-A7E4-4BFB03CF030C

P5875

Q34136980-CD426295-1FB0-4A3A-A953-CE445F47F0AC

P698

Q34136980-141FDF97-607E-428F-93A4-71BF47C058FF

P356

P1433

P1476

Histological diversity in chol ...... erent cholangiocyte phenotypes

@en

P2093

Baki Topal

http://www.w3.org/2001/XMLSchema#string

Chris Verslype

http://www.w3.org/2001/XMLSchema#string

Frederik Nevens

http://www.w3.org/2001/XMLSchema#string

Hirohisa Yano

http://www.w3.org/2001/XMLSchema#string

Jun Akiba

http://www.w3.org/2001/XMLSchema#string

Mina Komuta

http://www.w3.org/2001/XMLSchema#string

Raymond Aerts

http://www.w3.org/2001/XMLSchema#string

Vincent Vandecaveye

http://www.w3.org/2001/XMLSchema#string

Werner Van Steenbergen

http://www.w3.org/2001/XMLSchema#string

P2860

S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles

Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.

Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings.

Human hepatic stem cells from fetal and postnatal donors.

High expression of TROP2 correlates with poor prognosis in pancreatic cancer.

Hepatic progenitor cells: an update.

Anatomic pathology of hepatocellular carcinoma: impact on prognosis and response to therapy.

Molecular characterization of cultured adult human liver progenitor cells.

Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients.

A human combined hepatocellular and cholangiocarcinoma cell line (KMCH-2) that shows the features of hepatocellular carcinoma or cholangiocarcinoma under different growth conditions.

P304

1876-1888

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.25595

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Govaere

Jacques Pirenne

P577

2012-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221772065

http://www.w3.org/2001/XMLSchema#string

P698

22271564

http://www.w3.org/2001/XMLSchema#string